Year |
Citation |
Score |
2008 |
Salmon J, Ramos J, Callis J. Degradation of the auxin response factor ARF1. The Plant Journal : For Cell and Molecular Biology. 54: 118-28. PMID 18088308 DOI: 10.1111/J.1365-313X.2007.03396.X |
0.534 |
|
2006 |
Naumovski L, Sirisawad M, Lecane P, Chen J, Ramos J, Wang Z, Cortez C, Magda D, Thiemann P, Boswell G, Miles D, Cho DG, Sessler JL, Miller R. Tumor localization and antitumor efficacy of novel sapphyrin compounds. Molecular Cancer Therapeutics. 5: 2798-805. PMID 17121926 DOI: 10.1158/1535-7163.Mct-06-0246 |
0.309 |
|
2006 |
Ramos J, Sirisawad M, Miller R, Naumovski L. Motexafin gadolinium modulates levels of phosphorylated Akt and synergizes with inhibitors of Akt phosphorylation. Molecular Cancer Therapeutics. 5: 1176-82. PMID 16731749 DOI: 10.1158/1535-7163.Mct-05-0280 |
0.361 |
|
2006 |
Buggy J, Balasubramanian S, Ramos J, Sirisawad M, Naumovski L. Histone Deacetylase Inhibitor, PCI-24781, Induces Growth Inhibition and Apoptosis in Hematopoietic Tumor-Derived Cell Lines and Primary Leukemia Cells. Blood. 108: 4399-4399. DOI: 10.1182/Blood.V108.11.4399.4399 |
0.35 |
|
2005 |
Zhu Z, Ramos J, Kampa K, Adimoolam S, Sirisawad M, Yu Z, Chen D, Naumovski L, Lopez CD. Control of ASPP2/(53BP2L) protein levels by proteasomal degradation modulates p53 apoptotic function. The Journal of Biological Chemistry. 280: 34473-80. PMID 16091363 DOI: 10.1074/Jbc.M503736200 |
0.395 |
|
2005 |
Naumovski L, Ramos J, Sirisawad M, Chen J, Thiemann P, Lecane P, Magda D, Wang Z, Cortez C, Boswell G, Cho DG, Sessler J, Miller R. Sapphyrins induce apoptosis in hematopoietic tumor-derived cell lines and show in vivo antitumor activity Molecular Cancer Therapeutics. 4: 968-976. PMID 15956254 DOI: 10.1158/1535-7163.Mct-04-0339 |
0.405 |
|
2005 |
Chen J, Ramos J, Sirisawad M, Miller RA, Naumovski L. Motexafin Gadolinium Enhances Rituximab-Induced Cytotoxicity Against B-Cell Lymphoma Cell Lines: Role of Elevated Intracellular Calcium. Blood. 106: 4829-4829. DOI: 10.1182/Blood.V106.11.4829.4829 |
0.308 |
|
2005 |
Sirisawad M, Chen J, Ramos J, Miller RA, Naumovski L. Motexafin Gadolinium and Other Metallotexaphyrins Upregulate Heme Oxygenase-1. Blood. 106: 4468-4468. DOI: 10.1182/Blood.V106.11.4468.4468 |
0.351 |
|
2005 |
Ramos J, Sirisawad M, Chen J, Miller RA, Naumovski L. Growth Inhibition or Apoptosis after Treatment with Motexafin Gadolinium and Celecoxib Is Cell Line Dependent and Correlates with p27 Levels. Blood. 106: 4296-4296. DOI: 10.1182/Blood.V106.11.4296.4296 |
0.369 |
|
2005 |
Ramos J, Sirisawad M, Miller RA, Naumovski L. Motexafin Gadolinium Upregulates pAkt Levels and Synergizes with Inhibitors of Akt Phosphorylation. Blood. 106: 4275-4275. DOI: 10.1182/Blood.V106.11.4275.4275 |
0.356 |
|
2004 |
Chen J, Ramos J, Sirisawad M, Miller RA, Naumovski L. Motexafin Gadolinium Enhances Rituximab-Induced Cytotoxicity Against B-Cell Lymphoma Cell Lines. Blood. 104: 2296-2296. DOI: 10.1182/Blood.V104.11.2296.2296 |
0.343 |
|
2001 |
Ramos JA, Zenser N, Leyser O, Callis J. Rapid degradation of auxin/indoleacetic acid proteins requires conserved amino acids of domain II and is proteasome dependent. The Plant Cell. 13: 2349-60. PMID 11595806 DOI: 10.1105/Tpc.010244 |
0.532 |
|
2000 |
Worley CK, Zenser N, Ramos J, Rouse D, Leyser O, Theologis A, Callis J. Degradation of Aux/IAA proteins is essential for normal auxin signalling Plant Journal. 21: 553-562. PMID 10758506 DOI: 10.1046/J.1365-313X.2000.00703.X |
0.553 |
|
Show low-probability matches. |